博宁联合化疗治疗骨转移癌所致疼痛的疗效观察  

The Observation of the Effect in the Treatment of Pains Caused by Bone Metastasis with Pamidronate and Combined Chemotherapy

作　　者：王彩莲[1] 陈宝安[1] 张琳[1] 

机构地区：[1]东南大学附属中大医院血液肿瘤科,南京市210009

出　　处：《中国肿瘤临床》2003年第4期273-275,共3页Chinese Journal of Clinical Oncology

摘　　要：选择理想的治疗骨转移癌所致疼痛的方法。方法:以博宁联合化疗或以153Sm-EDTMP内照射联合化疗治疗52例骨转移癌。结果:治疗组总有效率为84.00%,对照组总有效率为59.26%。结论:治疗骨转移癌所致的骨痛,以博宁联合化疗为主的方法优于153Sm-EDTMP内照射联合化疗的方法。Objective:To select ideal treating method for bone metastasis.Methods:52cases of bone metastasis were treated by Pamidronate with combined chemotherapy and by 153 Sm-EDTMP with combined chemotherapy.Results:The total efficacy was84%compared to that of59.26%in the control.Conclusion:In treating the bone pain caused by bone metastasis,the method of combined chemotherapy of Pamidronate is superior to the method of combined chemotherapy of 153 Sm-EDTMP irradiation.

关 键 词：骨转移癌 博宁 ^153SM-EDTMP 内照射 化疗 

分 类 号：R738.1[医药卫生—肿瘤]